ANTIRETROVIRAL DRUGS - IMPLICATIONS FOR DENTAL PRESCRIBING

Many patients with HIV/AIDS are now being treated with two or more dru gs to reduce HIV viraemia and boost CD4 T-cell counts. Patients are us ing these dregs earlier in the course of their disease and so GDPs are likely to encounter them in practice. The drugs have dramatically alt ered short term prognosis bet are patent and have potentially serious drug interactions. Some of these drugs have interactions with drugs us ed in the dental care setting and this paper sets out to summarise tho se that are relevant in this area.